BXP vs CGEM · rev $3.48B vs $830.3M cap
Boston Properties Inc (BXP) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
BXP currently screens at market cap $12.12B. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the BXP and CGEM stock pages for the full models.
Not investment advice.